Affordable Access

Publisher Website

HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights.

  • Shacklett, Barbara L1
  • Blanco, Julià2, 3
  • Hightow-Weidman, Lisa4
  • Mgodi, Nyaradzo5
  • Alcamí, José6
  • Buchbinder, Susan7
  • Chirenje, Mike5
  • Dabee, Smritee8
  • Diallo, Mamadou9
  • Dumchev, Kostyantyn10
  • Herrera, Carolina11
  • Levy, Matthew E12
  • Martin Gayo, Enrique13
  • Makoah, Nigel Aminake14
  • Mitchell, Kate M15, 16
  • Mugwanya, Kenneth17
  • Reddy, Krishnaveni18
  • Rodríguez, Maria Luisa2
  • Rodriguez-Garcia, Marta19
  • Shover, Chelsea L20
  • And 8 more
  • 1 1 Medical Microbiology and Immunology, University of California, Davis, Davis, California.
  • 2 2 IrsiCaixa, IGTP, Barcelona, Spain. , (Spain)
  • 3 3 Chair in AIDS and Related Illnesses, Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic-UCC, Barcelona, Spain. , (Spain)
  • 4 4 Division of Infectious Diseases, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina.
  • 5 5 University of Zimbabwe College of Health Sciences, Harare, Zimbabwe. , (Zimbabwe)
  • 6 6 AIDS Immunopathology Unit, Instituto de Salud Carlos III, Madrid, Spain. , (Spain)
  • 7 7 San Francisco Department of Public Health, San Francisco, California.
  • 8 8 Division of Medical Virology, University of Cape Town, Cape Town, South Africa. , (South Africa)
  • 9 9 Department of Social and Preventive Medicine, University Laval, Quebec, Canada. , (Canada)
  • 10 10 Research, Ukrainian Institute on Public Health Policy, Kyiv, Ukraine. , (Ukraine)
  • 11 11 Faculty of Medicine, Department of Medicine, Imperial College London, London, United Kingdom. , (United Kingdom)
  • 12 12 Department of Epidemiology and Biostatistics, The George Washington University, Washington, District of Columbia.
  • 13 13 Immunology Department, Hospital Universitario La Princesa, Universidad Autónoma de Madrid, Madrid, Spain. , (Spain)
  • 14 14 Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa. , (South Africa)
  • 15 15 MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, United Kingdom. , (United Kingdom)
  • 16 16 HPTN Modelling Centre, Imperial College London, London, United Kingdom. , (United Kingdom)
  • 17 17 Department of Epidemiology, University of Washington, Seattle, Washington.
  • 18 18 Wits Reproductive Health and HIV Institute, University of the Witwatersrand, School of Clinical Medicine, Johannesburg, South Africa. , (South Africa)
  • 19 19 Department of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. , (Lebanon)
  • 20 20 Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California.
  • 21 21 Department of Infection and Immunology, Translational Health Science and Technology Institute, Faridabad, India. , (India)
  • 22 22 Departments of Surgery, Immunology, and Molecular Genetics and Microbiology, Duke University, Durham, North Carolina.
  • 23 23 Population Council, New York, New York.
  • 24 24 AVAC, New York, New York.
  • 25 25 Global HIV Vaccine Enterprise, New York, New York.
  • 26 26 International AIDS Society, Geneva, Switzerland. , (Switzerland)
Published Article
AIDS Research and Human Retroviruses
Mary Ann Liebert
Publication Date
Jul 01, 2019
DOI: 10.1089/AID.2019.0074
PMID: 31007035


The HIV Research for Prevention (HIVR4P) conference is dedicated to advancing HIV prevention research, responding to a growing consensus that effective and durable prevention will require a combination of approaches as well as unprecedented collaboration among scientists, practitioners, and community workers from different fields and geographic areas. The conference theme in 2018, "From Research to Impact," acknowledged an increasing focus on translation of promising research findings into practical, accessible, and affordable HIV prevention options for those who need them worldwide. HIVR4P 2018 was held in Madrid, Spain, on 21-25 October, with >1,400 participants from 52 countries around the globe, representing all aspects of HIV prevention research and implementation. The program included 137 oral and 610 poster presentations. This article presents a brief summary of highlights from the conference. More detailed information, complete abstracts as well as webcasts and daily Rapporteur summaries may be found on the conference website.

Report this publication


Seen <100 times